Funda Tayfun Kupesiz

Dr. Funda Tayfun Kupesiz


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025
Verified
Journal Article
Open access
OTOnur Tekeli
Onur Tekeli
TTTuğce Tural-Kara
Tuğce Tural-Kara
HÇHafize Selma Çetin
Hafize Selma Çetin
HKHatice Burcu Çağlar Kızıl
Hatice Burcu Çağlar Kızıl
AAAyşe Kübra Açık
Ayşe Kübra Açık
MOMeral Dilara Oğünç
Meral Dilara Oğünç
Rhizobium spp. strains (formerly classified as Agrobacterium based on 16S rDNA analysis) are aerobic, motile, oxidase-positive, non-spore-forming gram-negative bacilli. Clinical manifestations associated with Rhizobium radiobacter infections vary widely, with bacteremia typically linked to intravenous catheter use. This study analyzes the clinical and laboratory characteristics of 11 pediatric hematology and oncology patients at a tertiary referral hospital who had Rhizobium radiobacter-associated bloodstream infections over a 3-month period. Nine of the patients were male, and hematologic malignancy was the primary diagnosis in seven patients. Common risk factors included hospitalization within the last month, chemotherapy treatment, and the presence of an indwelling central venous catheter in all cases. Rhizobium radiobacter growth was detected an average of 13.5±16.6 days (range 1-54 days) after hospital admission, with 36% of patients being neutropenic at the time of culture positivity. Rhizobium radiobacter growth was detected in both catheter and peripheral blood cultures in six patients, whereas the microorganism was isolated exclusively from catheter cultures in four patients. Ten patients received antibiotic lock therapy, predominantly with amikacin (90%). Systemic antibiotic treatment involved a combination of beta-lactam and aminoglycoside antibiotics in 10 patients. Culture sterility was achieved in nine patients by the third day of antibiotic treatment. There were no cases of catheter extraction, thrombophlebitis, cardiac vegetation, reproductive complications, or mortality. In this first pediatric case series utilizing antibiotic lock therapy, effective treatment, strict isolation, and surveillance screenings led to favorable clinical outcomes for Rhizobium radiobacter-associated bloodstream infections in children with hematologic and oncologic conditions.

15 December 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
FKFunda Tayfun Kupesiz
Funda Tayfun Kupesiz
AAAyşe Nur Akınel
Ayşe Nur Akınel
HAHilal Akbaş
Hilal Akbaş
ÇSÇiğdem Sivrice
Çiğdem Sivrice
GKGülen Tüysüz Kintrup
Gülen Tüysüz Kintrup
EGElif Güler
Elif Güler
Background: Hepatoblastoma is rare cancer that responds well to risk-based chemotherapy, and surgical treatment is needed to achieve complete remission and satisfactory survival rates in hepatoblastoma patients. In this study, we evaluated the clinical features and treatment outcomes of pediatric hepatoblastoma patients treated in our clinic. Methods: Eighteen patients with hepatoblastoma who were treated and followed up in our center between June 1999 and June 2020 were analyzed retrospectively. All patients were evaluated by a multidisciplinary team and managed using a risk-based protocol (SIOPEL-1 and SIOPEL-3). Results: The patients’ mean age at diagnosis was 38.33 ± 52.34 months. Sixteen patients (89%) received neoadjuvant chemotherapy, and 2 patients (11%) who underwent complete mass excision at diagnosis received adjuvant chemotherapy. After neoadjuvant therapy, the tumor was completely resected in 8 patients (45%), while liver transplantation was performed in 6 patients (34%) because complete resection of the tumor was not possible. Two patients died before surgical treatment. One patient relapsed with lung metastasis after salvage chemotherapy. She is alive without disease at 64 months. The mean follow-up time was 59.3 ± 49.8 months; 5-year overall and disease-free survival rates were 88.9% and 80.8%, respectively. The 5-year overall survival rate was 100% for both liver transplant and resected patients, whereas 5-year disease-free survival was lower in transplant patients (75% vs 100%, P < .001). Conclusion: Multidisciplinary follow-up is especially important for patients who may need liver transplantation. Some patients may benefit from new treatment options such as radiofrequency ablation and cyberknife treatment. Cite this article as: Tayfun Küpesiz F, Akınel AN, Akbaş H, et al. Multidisciplinary management of pediatric hepatoblastoma: A 20-year single-center experience. Turk J Gastroenterol. 2022;33(12):1069-1078.

21 March 2022 in Pediatric Allergy, Immunology, and Pulmonology
Verified
Journal Article
Closed access
ZKZeynep Kihtir
Zeynep Kihtir
KCKIYMET CELIK
KIYMET CELIK
FKFunda Tayfun Kupesiz
Funda Tayfun Kupesiz
OKOsman Alphan Kupesiz
Osman Alphan Kupesiz
DUDilara Fatma Kocacik Uygun
Dilara Fatma Kocacik Uygun
ABAyşen Bingöl
Ayşen Bingöl
Background: Specific granule deficiency (SGD) is a rare immunodeficiency associated with CCAT/enhancer-binding protein epsilon (CEBPE) gene variants. It can cause severe recurrent infections and is lethal without successful stem cell transplantation. Few cases with SGD of both type 1 and type 2 have been described in the literature. In this study, we present the first report of a case with a novel homozygous c.511 C > T (p.Gln171Ter) mutation in the SMARCD2 gene of SGD type 2, which was successfully treated with bone marrow transplantation. Case: A male infant presented to our neonatal intensive care unit on the second day of life with an icteric appearance and mild hypotonia. He was evaluated for immunodeficiency as the cause of delayed cord separation and refractory neutropenia. At 6 weeks of age, SGD type 2 with a new variant was diagnosed and successfully treated by bone marrow transplantation. Conclusion: SGD is an immunodeficiency disease that is quite rare. However, we believe that SGD diagnosis and associated new variants can be detected more frequently with the widespread use of all whole-exome sequencing techniques.

2 November 2020 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
HYHatice Yazısız
Hatice Yazısız
VUVedat Uygun
Vedat Uygun
DÇDilek Çolak
Dilek Çolak
DMDerya Mutlu
Derya Mutlu
VHVolkan Hazar
Volkan Hazar
FKFunda Tayfun Kupesiz
Funda Tayfun Kupesiz


30 April 2022 in Tıp Eğitimi Dünyası
Verified
Journal Article
Closed access
FKFunda Tayfun Kupesiz
Funda Tayfun Kupesiz
EGErol Gürpinar
Erol Gürpinar
Aim: Learning style can be defined as individual differences in the processes of perceiving information, processing, and placing information in the mind. Creating educational models and learning environmentssuitable for individuals' learning style characteristics will ensure that desired learning outcomes are achieved. Kolb Learning Styles Scale is frequently used to determine learning styles. In our country andin the literature, there is no study evaluating the learning styles of physicians related to minör specializations. With this research, it was aimed to determine the learning styles of hematology specialists.Methods: Kolb learning styles scale and questionnaire were applied to hematology specialists who participated in the "Masterclass" program organized by the Turkish Society of Hematology between 2016-2019, using the online survey monkey method.Results: 70 hematologists from five different masterclass programs participated in the study. Of the hematologists, 61.4% (n= 43) were female and 38.6% (n= 27) were male. The mean age of the participants was calculated as 40 ± 3.16 years [median=39.96 years (35-54)], and the mean duration of specialistic was 4.81 ± 11.39 years [median= 5 (1-10 years)]. The learning style of hematologists is converging with 38 people (54.3%), assimilating with 16 people (22.9%), accommodating with 10 (14.3%), and diverging with 6 people (8.6%) was defined. There was no significant difference in terms of gender, major specialization, titles, institutions, and learning styles of the participants (p> .05). The mean final exam scores of the hematologists were calculated as 63.96 ± 10.99 points [median= 62 (40-91 points)]. It was observed that gender, age, duration of specialization, major specialization, academic title, and learning style had no effect on the final exam score (p>.05).Conclusions: Hematology specialists were found to have predominantly converging and assimilating learning styles. Considering the characteristics of these learning styles while creating hematology education programs and learning environments can contribute positively to traning program.